Using XACDURO
Dosing and administration
Quick reference
Dosing for patients 18 years of age and older
Dosing Information
XACDURO IS A CO‑PACKAGED PRODUCT CONTAINING SULBACTAM 1 g AND DURLOBACTAM 1 g1
Slide table to view more
| XACDURO Dosing | Estimated CLcr* (mL/min) | Frequency |
|---|---|---|
| sulbactam 1 g and durlobactam 1 g | Greater than or equal to 130 | Every 4 hours |
| 45 to 129 | Every 6 hours | |
| 30 to 44 | Every 8 hours | |
| 15 to 29 | Every 12 hours | |
| less than 15† | For patients initiating XACDURO: Every 12 hours for the first 3 doses (0, 12, and 24 hours), followed by every 24 hours after the third dose† For patients currently receiving XACDURO whose CLcr declines to less than 15 mL/min: Every 24 hours |
Administer all doses of XACDURO by intravenous infusion over 3 hours.
The recommended duration of treatment with XACDURO is 7 to 14 days.
The duration of therapy should be guided by the patient's clinical status.
- For more information on dosing and administration, see Full Prescribing Information
- For patients with fluctuating renal function, monitor CLcr and adjust dosage accordingly
CLcr=creatinine clearance estimated by Cockcroft-Gault equation.
For patients on hemodialysis, the dose should be administered after the dialysis session has ended.
Preparation steps1
1
Reconstitute the sulbactam 1 g single-dose vial with 5 mL of Sterile Water for Injection and gently shake to dissolve. Each reconstituted vial contains 1 g of sulbactam per 5 mL of clear, colorless to slightly yellow solution.‡
2
Reconstitute each of the 2 durlobactam 0.5 g single-dose vials with 2.5 mL of Sterile Water for Injection and gently shake to dissolve. Each reconstituted vial contains 0.5 g of durlobactam per 2.5 mL of clear, light yellow to orange solution.‡
3
To prepare the required dose, withdraw 5 mL of reconstituted sulbactam and 5 mL (2.5 mL from each vial) of reconstituted durlobactam. Add the withdrawn volume of both sulbactam and durlobactam to a 100 mL infusion bag of 0.9% Sodium Chloride for Injection, USP. Discard unused portion.
The reconstituted solution is not for direct injection and must be diluted before intravenous infusion. Dilution must occur within 1 hour of reconstitution
Inspect visually for particulate matter and discoloration prior to administration.
The prepared XACDURO solution should appear as a clear, light yellow to orange solution, free of particulates. If the XACDURO solution is cloudy or contains particulates, do not administer.
How to administer and store1
Want to know more?
Request to speak with a XACDURO sales representative or receive information.
Treat with Precision.
Choose pathogen-targeted coverage for HABP/VABP caused by susceptible isolates of Acinetobacter baumannii-calcoaceticus complex with XACDURO.2
References:
1. XACDURO®. Package Insert. Innoviva Specialty Therapeutics, Inc.; 2023. 2. Kaye KS, et al. Lancet Infect Dis. 2023;11:s1473‑3099(23)00184‑6. doi:10.1016/s1473‑3099(23)00184‑6